Skip to main content

Table 2 Breast tumour characteristics on mammography, ultrasound and PET at baseline according to drug regimen

From: The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET

 

TAX → FEC

FEC → TAX

P valuea

Total number

31

29

 

Ultrasound (volume)b

10,669 (702 to 169,221)

11,344 (919 to 121,428)

0.49

Mammography (volume)c

1,685 (0 to 7,487)

1,739 (0 to 5,749)

0.95

PET (SUVmax)

6.76 (1.58 to 24.8)

6.26 (2.3 to 26.6)

0.98

  1. Data presented as median (range). TAX, docetaxel (Taxotere®); FEC, combined flourouracil-epirubicin-cyclophosphamide anthracycline-based chemotherapy; PET, positron emission tomography; SUVmax, maximal standard uptake volume. aMann-Whitney U test. bVolume based on calculation of elliptical tumour shape. cVolume based on the sum of areas in the craniocaudal and mediolateral oblique appearance.